Imricor startet die VISABL-VT-Studie mit der ersten Echtzeit-MRT-geführten ... - published 10 Apr 2025 #ClinicalTrials #News #ASX #Grafa #ico
https://grafa.com/news/de-health-imricor-starts-visabl-vt-trial-with-first-real-time-mri-guided-ventricular-ablation-420619?utm_source=asx_news_de&utm_medium=mastodon&utm_campaign=420619
Imricor starts VISABL-VT trial with first real-time MRI-guided ventricular ... - published 10 Apr 2025 #ClinicalTrials #News #ASX #Grafa #ico
https://grafa.com/news/health-imricor-starts-visabl-vt-trial-with-first-real-time-mri-guided-ventricular-ablation-420606?utm_source=asx_news_en&utm_medium=mastodon&utm_campaign=420606
Imricor Medical Systems ( #IMR ) has released " Imricor Commences VISABL-VT Clinical Trial " on Fri 11 Apr at 08:40 AEST #today #UnitedStates #ClinicalTrials #Australia #News
https://grafa.com/asset/imricor-medical-systems-inc-2502-imr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imr.asx
Immuron ( #IMC ) has released " Immuron Travelan highest sales in history " on Thu 10 Apr at 11:20 AEST #government #ClinicalTrials #Australia #media #Strategy
https://grafa.com/asset/immuron-ltd-2491-imc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=imc.asx
Alterity Therapeutics ( #ATH ) has released " Alterity Presents Encouraging New Phase 2 Data in MSA " on Thu 10 Apr at 10:11 AEST #today #ClinicalTrials #Gold #Australia #media
https://grafa.com/asset/alterity-therapeutics-ltd-641-ath.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ath.asx
Tryptamine Therapeutics Limited ( #TYP ) has released " TRP-8803 BED trial to commence with Swinburne this quarter " on Thu 10 Apr at 09:15 AEST #Mining #ClinicalTrials #Australia #News #media
https://grafa.com/asset/tryptamine-therapeutics-limited-26766-typ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=typ.asx
PYC Therapeutics ( #PYC ) has released " First Subject Dosed in PKD Clinical Trial " on Thu 10 Apr at 08:45 AEST #today #ClinicalTrials #Australia #media #live
https://grafa.com/asset/pyc-therapeutics-ltd-3821-pyc.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=pyc.asx
What #NIH #Layoffs Mean for #Cancer Patients
In the rush of headlines about budgets and restructuring, it’s easy to miss what’s really at stake. But working in cancer innovation and advocacy: when we delay #science, we delay survival. When we dismantle #research infrastructure, people #die waiting. Thousands at #NIH and #HHS were laid off. These were the people running #clinicaltrials, developing new treatment strategies, and pushing promising therapies toward approval.
https://scilight.substack.com/p/what-nih-layoffs-mean-for-cancer
Valneva starts key Phase 2 infant vaccine trial in Kenya - published 09 Apr 2025 #today #ClinicalTrials #Tech #BioTech #Grafa
https://grafa.com/news/health-valneva-starts-key-phase-2-infant-vaccine-trial-in-kenya-419157?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=419157
IDT Australia ( #IDT ) has released " New $3.2M Contract Supports Australia's Largest API Plant " on Wed 09 Apr at 09:40 AEST #ClinicalTrials #Australia #media #Strategy #ltd
https://grafa.com/asset/idt-australia-ltd-7707-idt.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=idt.asx
Orthocell ( #OCC ) has released " Regulatory Approval for Striate in US$65M Brazilian Market " on Wed 09 Apr at 09:19 AEST #ClinicalTrials #Australia #media #Strategy #live
https://grafa.com/asset/orthocell-ltd-177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx
Nyrada ( #NYR ) has released " Phase I Clinical Trial Dosing Update No 1 " on Wed 09 Apr at 08:22 AEST #today #ClinicalTrials #Australia #media #live
https://grafa.com/asset/nyrada-inc-3430-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx
Nyrada ( #NYR ) has released " Significant Neuroprotection in Traumatic Brain Injury Study " on Mon 07 Apr at 08:27 AEST #today #ClinicalTrials #Australia #media #ASX
https://grafa.com/asset/nyrada-inc-3430-nyr.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nyr.asx
New drug from Spain’s University of Barcelona offers hope for Alzheimer’s sufferers https://www.byteseu.com/897515/ #Alzheimer'sDiseaseDrug #barcelona #ClinicalTrials #Health #NewsSpain #newspaper #Spain #TheOlivePress #UniversityOfBarcelonaResearch
National Library of Medicine: ClinicalTrials.gov: A 25-Year Journey to a Half-Million Registered Studies. “Since its launch in 2000, ClinicalTrials.gov has been a reliable registry and results database for clinical trials from the National Institutes of Health and NLM. In 2005, ClinicalTrials.gov broadened its reach to include information on clinical studies around the world, covering a wide […]
Arvinas presents promising Phase 1 data for ARV-102, a novel LRRK2 degrader - published 04 Apr 2025 #today #ClinicalTrials #Tech #BioTech #Grafa
https://grafa.com/news/health-arvinas-presents-promising-phase-1-data-for-arv-102--a-novel-lrrk2-degrader-415360?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=415360
Orthocell ( #OCC ) has released " Remplir Cleared to Commence Sales in US$1.6B US Market " on Fri 04 Apr at 09:23 AEST #ClinicalTrials #Australia #media #Strategy #live
https://grafa.com/asset/orthocell-ltd-177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx
Enlivex Therapeutics initiates Phase I trial for TMJ osteoarthritis treatme... - published 03 Apr 2025 #ClinicalTrials #News #live #ltd #Grafa
https://grafa.com/news/health-enlivex-therapeutics-initiates-phase-i-trial-for-tmj-osteoarthritis-treatment-with-allocetra--414172?utm_source=us_news_en&utm_medium=mastodon&utm_campaign=414172
Orthocell ( #OCC ) has released " Trading Halt " on Thu 03 Apr at 09:06 AEST #trading #ClinicalTrials #Australia #media #Strategy
https://grafa.com/asset/orthocell-ltd-177-occ.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=occ.asx
Race Oncology ( #RAC ) has released " RC220 Phase 1 Trial Opens for Patient Enrolment " on Thu 03 Apr at 08:57 AEST #UnitedStates #ClinicalTrials #Australia #media #live
https://grafa.com/asset/race-oncology-ltd-3890-rac.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=rac.asx
